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Among the major problems confronting mankind today, three have reached,
or are approaching the crisis level. These include first, a flagrant destruction of
our environment; second, our reproductive success and decreased death rate,
which have led to an unprecedented population explosion; and third, a deterioration
of the human gene pool. Both ecology and the population explosion are receiving
much attention these days, particularly since the political benefits of the former
have recently been discovered. But the prospect of human genetic modification,
either to decrease the frequencies of disadvantageous or lethal genes, or to modify
the human genotype in certain preselected directions, has received little attention
outside professional journals. Sober scientific thought concurs in the conclusion
that control of human evolution is, indeed, a prospect for "tomorrow or the day
after."
Our bank of genetic material is undergoing a slow but inexorable decline in
quality. Several dysgenic influences contribute heavily to this qualitative dilution.
Every successful technique which lengthens the life span of persons with inherited
defects increases the likelihood that such individuals will reproduce and pass on
their defective genes. Selection and survival of the less fit slowly but relentlessly
increase the frequencies of these genes and the probability that they will occur
in future generations. Moreover, the nearly continuous warfare in which man
chooses to engage tends to siphon off the physically fittest and, often, the intel-
lectually well endowed.
About three to four percent of all births carry some detectable, genetically
based defect. Many of the bearers of these defect-producing genes die, some very
early, others a little later, and a great many can look ahead only to a life of greater
or lesser misery if, indeed, their deficiencies are not such as to impair their mental
processes. An additional but unknown number of fetuses, homozygous for reces-
sive lethal genes, abort spontaneously. Quite aside from considerations of birth
control and death control, those who are born ought to have a chance for life free
from this type of defect. On the other hand, they should not serve as additional
sources of input for deleterious genes.
Three avenues of approach are available in meeting this kind of problem:
(1) directed recombination, involving selection of those genes which will be permitted
to perpetuate themselves; (2) overriding the expression of defect-producing genes
without trying to control their frequencies; and (3) modifying or even replacing
the defective genes themselves—that is, genetic surgery. These three approaches
really translate themselves into the twin questions, "Can man control his own
evolution?" and "If so, should he?" The first of these two questions lies in the
province of the scientist, whereas the second, raising, as it does, profound moral,
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legal, and ethical considerations, will shortly concern all rational, thinking persons.
I want to explore these matters briefly, raising questions and considering related
problems. We shall not come to many final answers here; rather, we shall have
to await the intelligent judgment of those who today are our students.
In some ways, gene selection, or directed recombination, is mechanically the
easiest, though not necessarily the most satisfactory, solution to the problem of
quality control in the human gene pool. It requires no sophisticated equipment,
no techniques which have not been available, even practiced in other species, for
years. Basically, it involves only the selection of parental stocks, those whose
genes will be transmitted to future generations. The oldest technique would
merely restrict child-bearing to those best fitted to perpetuate the species. But
this raises significant problems. What are the standards? Who makes the
decisions? Racially pernicious, politically unsound, such a solution is at best
impractical, at worst dangerous.
Heterozygous "carriers" of defect-producing genes can now be identified by
relatively simple tests in such varied inherited metabolic diseases as sickle-cell
trait, cystic fibrosis, and galactosemia. Could we not limit or prevent reproduction
by such persons? The problem of how that control might be accomplished
becomes a very personal one when we remember that each of us carries at least
one, and probably several, such lethal, semi-lethal, or disabling genes. Should
control be exercised through advice and counseling? On a distressingly small
scale we are doing this now. Should it be by governmental restraint, by legislation,
with penalties for breaking the law, or even by compulsory sterilization? Once
again, the question of who should make these judgments is an exceedingly difficult
one. But, viewed coldly and impersonally, this approach does offer the advantage
of being possible now in many instances, for it requires little more in the way of
precise genetic knowledge than we already have.
If the concept of selective parenthood seems repugnant or impractical or
dangerous, there is the additional problem of whether to allow fetuses that will
express defective genes or which have been damaged by such drugs as thalidomide
or LSD to come to term. To permit them to do so is regarded by some as the
deepest kind of cruelty, both to the new person and to his family. By others, not
to do so is classed as murder. The philosophy underlying selective, legalized
abortion may well need reexamination. Both Colorado and Hawaii have recently
taken significant forward steps in this regard, and an even more liberal reform hasjust been passed by the New York legislature.
On the other hand, still another avenue of directed recombination is, even now,
open. Before long it may become much more practical as our knowledge of the
human genotype and linkage groups increases. Rather than select certain persons
who shall or shall not become parents, or which embryos will be allowed to mature,
we may select the reproductive cells themselves. To a degree this is practiced now.
Artificial insemination, so long applied with rather successful results in animal
breeding, is currently used to a much more limited extent with mankind. But all
too often no account is taken of the genetic constitution of the prospective mother
and little more of the sperm donor. Ordinarily the goal is merely the fact of child
production in families where it would otherwise not be possible and, incidentally,
to produce children who could be mistaken for those of the non-biological father.
The late Herman Muller (1965) proposed setting up sperm and egg banks,
since sex cells can be kept alive and functional for considerable periods by freezing.
Muller proposed such banks, with the most desirable male and female subjects
serving as donors. By whatever standards that might be set up, the best sources
could continue so to serve for a considerable period after their deaths and, with
suitable precautions, even after a nuclear war. The question of determining
genetic desirability here is of course no easier than in other systems of restrictive
parenthood. But Muller expressed hope in these words: "With the coming of a
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better understanding of genetics and evolution, the individual's fixation on the
attempted perpetuation of just his particular genes will be bound to fade. It will
be superseded by a more rational view . . . he will condemn as childish conceit the
notion that there is any reason for his unessential peculiarities, idiosyncrasies and
foibles to be expressed generation after generation." Society has not reached the
stage of objectivity envisioned by Muller, of course, and gamete banks still entail
an element of chance in recombination of disadvantageous genes, though the
overall probability might be lower than in a system of random mating.
The techniques are, again, relatively simple. Use of sperm requires no more
elaborate methods than those currently used in the practice of artificial insemina-
tion. Implantation of selected eggs, fertilized or unfertilized, is already a fact in
laboratory animals and involves little that is new for adaptation to humans.
Early this year a team of British doctors disclosed that an egg, already fertilized
in vitro by sperm from the husband, is to be implanted in the womb of a woman
who cannot conceive because of an obstruction in her fallopian tubes. It is
entirely possible that the first test-tube conceived child will be born this year.
Certainly there are difficulties ahead, and many presently unanticipated problems
will doubtless arise. But work in this direction is going on, and success will come.
Once the process of implantation is perfected, the prospects are virtually
limitless. The prominent British embryologist Cohen suggests the possibility
of a system of volunteer "host" mothers who would bear other people's children
for a fee where, perhaps, it may be physically unwise for a woman to undertake
the risks and rigors of pregnancy, or even in case she simply does not wish to
interrupt a career. Or, an infertile woman could bear children who are the product
of her husband's sperm and ova from an unknown donor; such a fertilized egg
might simply then be implanted in her body. Of course, the matter is more
complicated than I appear to suggest, but surely it will be feasible in the relatively
near future.
Some writers, only partly with tongue in cheek, have compared human germinal
choice to selection of a packet of desirable flower seeds in the supermarket. The
container could carry a brief statement of the most probable traits, from intelligence
to physical perfection and even sex; selection could be made as simply as deciding
on the kind of plants to grow. Prom the psychological standpoint, there is con-
siderable doubt that man is ready for this, and our genetic knowledge of the human
species is not yet up to our understanding of marigolds and petunias.
When it is, perhaps rather than implant an egg in a human female, we could
not only select sperm and egg and bring about fertilization in vitro, but even raise
the embryo to term in a glass womb. In fact, Petrucci in Italy is said to have
raised human embryos in this way for as long as two months, and then deliberately
terminated the experiment. The moral question "Is it murder"? is reported to
have deeply disturbed him as a Catholic. Others have worked and are working
along these lines and someday, somewhere, someone is going to be successful in
producing such a person. Think of the cognate problems: who is he? who is
or are his parents? what are his legal rights? Will we mass-produce a new race
of slaves? One day these questions, and more, are going to have to be answered.
Further afield, but interesting speculatively, is the possibility of vegetative
multiplication. It has long been possible to maintain cultures of human cells;
will it eventually be possible to induce differentiation and thereby create unlimited
numbers of identical individuals to certain specific genetic designs? Already we
can do this with lower forms of life, and some scientists feel it is more a question
of "when" than "if." Science fiction? Today, yes; but tomorrow? or the day
after ?
As another approach, consider the modification of the expression of the genes
that one has, or even of replacing certain genes with their alternative alleles.
Diabetes, for example, is a genetic disorder which affects several million persons
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in this country, many of whom are kept alive only by injection of the hormone,
insulin. This is one of the simpler proteins synthesized by the human body and its
structure is well known, consisting of two polypeptide chains, one of 21 amino
acid residues, the other of 30. It is formed only in certain cells of the pancreas
from its precursor protein, proinsulin. Proinsulin is manufactured in the usual
biological way, in which the appropriate base pair sequences of DNA are trans-
cribed into mRNA which, in the cytoplasm, together with the necessary amino
acids, ribosomes, enzymes, tRNA, and so forth, translates these sequences into
protein. Using Benzer's terminology, only two DNA cistrons, of some 63 and 90
nucleotide pairs, respectively, are involved, representing altogether only about
0.05 micron of the total length of human DNA.
All somatic cells are believed to contain all the genetic information of the
individual, yet only a very restricted group of cells synthesizes proinsulin. In
other cells of the body, the proinsulin cistrons are "turned off," or repressed.
Knowledge of the mechanism of gene repression in higher organisms is pro-
gressing rapidly, and one approach in treating diabetes may lie in learning
how to derepress the proinsulin cistrons, either in the cells where it is normally
produced or in other cells of the body. Once such activation has been achieved,
there remains the problem of conversion of proinsulin to insulin and its release
from the cells in which its synthesis is effected. By comparison, this may not
be difficult and might, indeed, occur naturally. But such derepression in somatic
cells, even for millions of diabetics, will have no effect in upgrading the human
gene pool.
On the other hand, we may be dealing not with repressed genes but rather with
cistrons whose deoxyribonucleotide sequence specifies a "wrong" series of amino
acids. Even a single base-pair change—for example, a switch from an adenine-
thymine pair to one of guanine-cytosine, or even from an adenine-thymine to a
thymine-adenine pair, or a deletion or an insertion of one nucleotide pair, can
code for an incorrect amino acid at given positions in the polypeptide chain and result
in the formation of an aberrant or a non-functional protein. This is the sort of
thing which spells the difference between normal hemoglobin A and hemoglobin S
which is associated with sickle-cell disease. Could such defective cistrons be
replaced by genetic surgery? In brief, the answer today for human beings is,
"No, not yet." But it can be done in bacteria, though we cannot yet control
very well which genes are replaced. One of the mechanisms by which this process
occurs naturally in bacteria is transduction, a process involving transfer of DNA
from one cell to another through the mediation of a bacterium-infecting virus, or
phage.
In the infection of a bacterium by a virulent phage, the virus DNA is replicated
in the bacterial cell, new protein shells of the virus are manufactured in the cyto-
plasm, and, after about half an hour, the bacterial cell bursts, releasing several
hundred new virus particles ready to repeat the process. The vast majority of
these contain DNA identical to that of the original infecting phage. But a very
few contain a segment of bacterial DNA from the host cell, replacing a correspond-
ing bit of viral DNA.
Some phages do not regularly produce this bursting and destruction of the
bacterial cell. These are the temperate phages, one of which is known as lambda.
Infection of a cell with lambda results in incorporation of some of the viral DNA
into the bacterial cell's DNA. The bacterial cell survives and multiplies, some
of its descendants containing DNA that includes sequences of nucleotides received
from the virus.
The question here is whether this same kind of transfer of genetic material
could be effected in the cells of higher organisms. There is evidence to suggest an
affirmative answer. Aaronson and Todaro (1969) reported that DNA isolated
from simian virus 40 can become established in human fibroblast cells in vitro
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and appears to express itself in protein synthesis in such cells. SV40 is a small
virus which produces tumors in appropriate animal hosts. Human cells in which
SV40 DNA has been incorporated undergo certain characteristic changes, including
loss of sensitivity to contact inhibition of cell division, and production of SV40-
specific mRNA. Such human cells also produce a new protein, the so-called
T-antigen, which persists in clonal cells. Aaronson and Todaro conclude their
report with these words: "There is considerable evidence [to show] that SV40
DNA can become a permanent part of the host cell genome. Most of the SV40
DNA in transformed cells is associated with the chromosomes . . . However, if
the viral DNA's ability to integrate into the human cell genome can be separated
from its [tumor producing property], it may then be possible to use 'integrating'
viral DNA to insert specific information into human cells." The important
point here for our purposes is the incorporation and persistence of viral DNA in
the human gene complement and its subsequent manifestation in specific new
protein synthesis.
Two additional recent discoveries complete the groundwork for human genetic
surgery. Rather than search for a convenient transducing virus carrying, say,
a stretch of DNA for proinsulin production, it should be possible sooner or later
to make it to order. In late 1967, Kornberg and his colleagues (Goulian, Kornberg,
and Sinsheimer, 1967) reported the synthesis of biologically active DNA, of phase
<£X-174, some 6,000 deoxyribonucleotides in length. It is true that this virus's
DNA is only single stranded and that to synthesize it these men used natural phage
DNA as a primer. But the important point is that functional DNA had been
manufactured experimentally for the first time.
Then just last November, Beckwith and his associates at Harvard (Shapiro,
et al., 1969) isolated and photographed a specific part of the lac operon, the segment
of DNA responsible for the metabolism of lactose in the colon bacillus (Escherichia
coli). They employed two transducing phages to obtain in pure form one cistron
which specifies beta-galactosidase, the first enzyme in the system, together with
the operator and promoter sites of the operon. These latter two are, in effect,
genetic "switches," which direct the cistron to start or stop production of the
specific mRNA which translates the genetic information of DNA into the poly-
peptide chains of the enzyme. The beta-galactosidase cistron consists of some
3,700 deoxyribonucleotide pairs, the operator and promoter sites together about
400. Hopefully, then, we will soon have the capability of isolating or synthesizing
a nucleotide sequence coding for proinsulin and, perhaps, even of packaging it in
a virus-like protein coat. Once the original synthesis or isolation has been per-
formed, it is done for all time; following Kornberg's methods (Goulian et al., 1967),
it can then be copied accurately forever.
By the same techniques and processes, then, any faulty or undesirable gene
could be changed, first in the somatic cells of individuals requiring such genetic
surgery, and next in the reproductive cells, for there are two facets to the task
here. It is one thing to modify the genetic material of the somatic cells, but to
exercise a quality control over human evolution, such modification will, of course,
also have to be made in the sex cells. We are, however, still left with the problem
of denning desirability in the genome; that is, desirability from whose viewpoint?
It seems to me that it is our compelling duty as scientists to continue vigorously
to push back the veil of the unknown, and to seek out the truth, wherever it may
lead. In that effort there must be no cessation. But it appears equally apparent
that, as scientists, we have the inalienable duty to point out the consequences of
the use or misuse of new discoveries. No scientist, I believe, should ever withhold
new facts or new techniques because of fear of where their misuse might lead.
But we should always be ready to alert the non-scientific community to potential
dangers of misapplication.
If a few small cistrons can be synthesized, next will come the possibility of
replicating the entire human DNA complement, literally making human beings
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to order with almost any set of predetermined characteristics. Combine, if you
will, this kind of genetic surgery or synthesis with the glass womb, and man will,
indeed, then control his own evolution, shaping it to suit whatever the need, good
or evil. And he will be able to do so, if not tomorrow, then surely the day after.
Truly, a new horizon in the history of man is just ahead. As Albert Rosenfeld
(1969) has written in this context, "The time ahead is wild and unchartered."
Wild and unchartered, yes; challenging to man's conscience, certainly; but assuredly
exciting beyond our present capacity to comprehend.
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